Target-selective MG53-containing extracellular vesicles delivery in acute and chronic kidney injury

Abstract Acute kidney injury (AKI) is a sudden loss of kidney function associated with high morbidity and mortality, and effective therapy remains an unmet need. We previously showed that MG53, a muscle-predominant protein, confers kidney protection against ischemia–reperfusion (I/R) injury and unilateral ureteral obstruction (UUO)-mediated kidney fibrosis. Here, we show that limb remote ischemic preconditioning (RIPC) partially attenuates tubular apoptosis alongside a trend toward functional renal improvement against I/R-AKI, an event accompanied by a systemic surge of circulating MG53-containing extracellular vesicles (EVs). While the exact systemic trafficking kinetics and precise tissue origins of this native endogenous pool remain a proposed working hypothesis, a stark, exclusive 2.3-fold upregulation of MG53 cargo occurs exclusively within the injured renal microenvironment. To evaluate the translational utility of this axis, we characterized exogenous MG53-containing EVs derived from C2C12 myotubes (EV C2C12 ) or engineered NIH3T3 cells (EV MMT ). Upon intravenous administration, these vehicles exhibited rapid, injury-dependent accumulation within damaged proximal tubules. Utilizing a chronic injection regimen, sustained delivery of these payloads successfully mitigated baseline renal functional defects (Scr and UPCR) in mg53 -/- mice. Finally, in vitro assays demonstrate that MG53-containing EVs uptake is closely associated with intracellular AKT activation and enhances proximal tubule cell metabolic activity during hypoxia/reoxygenation stress. In summary, this work underscores the reparative capacity of endogenous MG53 accumulation while establishing that exogenous vesicular delivery serves as a viable translational strategy within an integrated muscle-kidney crosstalk axis.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-14
DOI
https://doi.org/10.1038/s41598-026-78112-1
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Target-selective MG53-containing extracellular vesicles delivery in acute and chronic kidney injury

Pu Duann, Pei‐Hui Lin, Haichang Li, Brad H. Rovin et al.
Scientific Reports
Extracellular vesicles in disease
article

Target-selective MG53-containing extracellular vesicles delivery in acute and chronic kidney injury

Pu Duann, Pei‐Hui Lin, Haichang Li, Brad H. Rovin, Min Zhang
article en

Abstract

Abstract Acute kidney injury (AKI) is a sudden loss of kidney function associated with high morbidity and mortality, and effective therapy remains an unmet need. We previously showed that MG53, a muscle-predominant protein, confers kidney protection against ischemia–reperfusion (I/R) injury and unilateral ureteral obstruction (UUO)-mediated kidney fibrosis. Here, we show that limb remote ischemic preconditioning (RIPC) partially attenuates tubular apoptosis alongside a trend toward functional renal improvement against I/R-AKI, an event accompanied by a systemic surge of circulating MG53-containing extracellular vesicles (EVs). While the exact systemic trafficking kinetics and precise tissue origins of this native endogenous pool remain a proposed working hypothesis, a stark, exclusive 2.3-fold upregulation of MG53 cargo occurs exclusively within the injured renal microenvironment. To evaluate the translational utility of this axis, we characterized exogenous MG53-containing EVs derived from C2C12 myotubes (EV C2C12 ) or engineered NIH3T3 cells (EV MMT ). Upon intravenous administration, these vehicles exhibited rapid, injury-dependent accumulation within damaged proximal tubules. Utilizing a chronic injection regimen, sustained delivery of these payloads successfully mitigated baseline renal functional defects (Scr and UPCR) in mg53 -/- mice. Finally, in vitro assays demonstrate that MG53-containing EVs uptake is closely associated with intracellular AKT activation and enhances proximal tubule cell metabolic activity during hypoxia/reoxygenation stress. In summary, this work underscores the reparative capacity of endogenous MG53 accumulation while establishing that exogenous vesicular delivery serves as a viable translational strategy within an integrated muscle-kidney crosstalk axis.

Scientific Reports
The Ohio State University Wexner Medical Center (US), The Ohio State University (US)
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon